February 7, 2022
Medix Biochemica acquires myPOLS Biotec expanding molecular diagnostics portfolio
Medix Biochemica has acquired 100 percent of the shares of myPOLS Biotec GmbH. As a result of the acquisition, Medix…
Pharmaceuticals, Biotechnology and Life Sciences
Category: Business
February 3, 2022
Sanofi today unveiled a new bold and unifying corporate brand that supports the modernization and transformation the company launched in…
February 3, 2022
Hikma completes acquisition of Teligent sterile injectable assets
Hikma Pharmaceuticals PLC has completed acquisition of the Canadian assets of Teligent Inc. for $45.75 million. The acquisition marks Hikma’s…
October 12, 2021
Hikma launches Micafungin for Injection
Hikma Pharmaceuticals has announced it launched Micafungin for Injection through its US affiliate, Hikma Pharmaceuticals USA Inc. The company has launched 50mg and 100mg doses.
October 11, 2021
Sandoz completes acquisition of GSK’s cephalosporin business
Sandoz, a Novartis division, has acquired rights to three established brands (Zinnat, Zinacef and Fortum) in more than 100 markets,…
October 5, 2021
Bayer to invest over €400 million to increase access to modern contraception
Bayer announced to invest over €400 million, reinforcing its commitment to providing 100 million women and girls with access to…
April 22, 2021
BMS builds new cell therapy manufacturing facility in the Netherlands
Bristol Myers Squibb has selected Leiden, Netherlands to house a new cell therapy manufacturing site in Europe, leveraging the growing…
April 12, 2021
Sanofi acquires Tidal Therapeutics
Sanofi has acquired Tidal Therapeutics, a privately owned, pre-clinical stage biotech company with a novel mRNA-based approach for in vivo reprogramming…
March 31, 2021
GSK to support manufacture of Novavax’ COVID-19 vaccine
GSK has reached an agreement in principle with Novavax and the UK Government Vaccines Taskforce to support manufacturing of up…
March 25, 2021
AstraZeneca answers accusation to stockpiling vaccines; 13M doses for COVAX, 16M for Europe
AstraZeneca has denied accusations of stockpiling vaccines stating that the process of manufacturing vaccines is very complex and time consuming…